Results 41 to 50 of about 885 (152)

Cholinergic pathway suppresses pulmonary innate immunity facilitating pneumonia after stroke

open access: yes, 2015
Background and Purpose: Temporary immunosuppression has been identified as a major risk factor for the development of pneumonia after acute central nervous system injury.
Herold, S.   +12 more
core   +1 more source

Совместимость системных препаратов и местной гипотензивной терапии у пациентов с первичной открытоугольной глаукомой (аналитический обзор) [PDF]

open access: yes, 2019
The prevalence of glaucoma in the world today is extremely high: according to different authors total prevalence number reach as high as 66 to 105 million people.
A. S. Makarova   +3 more
core   +1 more source

Causes of blindness in the modern world and glaucoma as one of the leading causes

open access: yes, 2021
Sljepoća sa svojim socijalnim i ekonomskim posljedicama predstavlja teret svakom društvu. Etiologija sljepoće mijenjala se tijekom 20.stoljeća do danas.
Vidić, Monika
core  

Scientific Meetings: Some Aspects of Pharmacological Chemistry

open access: yes, 1949
A Summary of Three University Lectures given in the Department of Pharmacology, University College, London. January-February, 1949. Only the symptomatic drugs were considered in this series. The first lecture dealt with the significance of
F Bergel
core   +1 more source

Fármacos simpaticomiméticos y parasimpaticomiméticos [PDF]

open access: yes, 2017
Los fármacos simpaticomiméticos y parasimpaticomiméticos son conformados por una serie de medicamentos los cuales son empleados para diversos usos; en cuanto al grupo de las catecolaminas correspondientes a los simpaticomiméticos de acción directa éstos ...
Fernandez Zamora, Andrea
core  

Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy. [PDF]

open access: yesFront Neurol, 2023
Crescioli G   +10 more
europepmc   +1 more source

LA NOSTRA ESPERIENZA CON IL LATANOPROST NEL GLAUCOMA AD ANGOLO APERTO

open access: yes, 2000
Gli Autori, allo scopo di studiare la possibilità di applicare il Latanoprost ad una terapia antiglaucomatosa massimale, dimostratasi insufficiente a tenere sotto controllo la IOP, hanno esaminato 55 pazienti (109 occhi) affetti da GAA.
LIBRANDO, Aloisa   +2 more
core  

Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies. [PDF]

open access: yesAdv Ther
Novella A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy